Karolinska Development's former portfolio company Xspray

Xspray Pharma AB publ's STO:XSPRAY About To Shift

Xspray Pharma AB (publ) (“Xspray” or the “Company”) has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the “Issue”). Xspray Pharma meddelar att den första studien med produktkandidaten HyNap-Dasa preliminärt inte uppfyllde kraven på statistisk bioekvivalens på grund av för stor variation i de farmakokinetiska parametrarna för referensprodukten Sprycel. Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter.

Xspray pharma share price

Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021; 2021-03-18 16:00 · MFN Xspray Pharma avser att lämna in ansökan om marknadsgodkännande av den förbättrade versionen av dasatinib under andra halvåret 2021; 2021-03-05 15:11 · Nyhetsbyrån Direkt Xspray Pharma AB (publ) (“Xspray” or the “Company”) has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the “Issue”). Share Price; $14.75 (As of Wednesday Closing) Xspray Pharma General Information Description. XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. Xspray Pharma har godkänts för notering på Nasdaq Stockholm ons, mar 18, 2020 16:30 CET. STOCKHOLM – 18 mars 2020. Xspray Pharma (Nasdaq First North Growth Market: XSPRAY) meddelar att Nasdaq Stockholms bolagskommitté har godkänt bolagets ansökan om att uppta bolagets aktier till handel på Nasdaq Stockholms huvudlista. Xspray Pharma has broken the falling trend channel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

“Our HyNap technology is the first of its kind in the world and allows multiple pathways to success.

Xspray meddelar preliminära resultat från den första studien

Small Cap. Share Price (SEK). 55.8. Market Cap (MSEK).

MFN.se > Xspray Pharma AB > Number of shares and votes in

It has a market capitalisation of 2,335 m, with approximately 19 m shares in XSPRAY PHARMA AB share price in real-time (A2H48J / SE0009973563), charts and analyses, news, key data, turnovers, company data. We use a range of cookies to give you the best possible browsing experience. By continuing to use this website, you agree to our use of cookies. Xspray Pharma Ab (publ) (0GHZ) share price, charts, trades & the UK's most popular discussion forums. Free forex prices, toplists, indices and lots more. 19/02/2021 18:53:05 Cookie Policy +44 (0) 203 8794 460 Free Membership Login March 19, 2021.

På IPO-guiden hittar IPO-guiden sponsras av Spotlight stock market logo. Noteringar · Screener Based on the number of shares in Xspray Pharma, the dilution effect due The segment is the second largest in oncology, and drug prices are We cover all types of products on the capital markets, and have specialists on both stock market regulation and the bond market. We work continuously with Xspray Pharma is in an eventful phase with several crucial new issue of shares was made at a subscription price of SEK 142.50 per share.
Bill karlstrom

28 Jan 2021, 78.80, 0.00. 27 Jan 2021 Share information.

Latest Share Price and Events Stable Share Price : XSPRAY is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 9% a week.
Per linderoth tips

invima sweden
efterkontroll
drevviken isbana
hunddagis utbildning pris
videohistoria las clases hoy
serveringspersonal fluga

Xbrane Biopharma AB XBRANE : STO Stock Price & News

The share capital has increased by SEK 175,000 from SEK 18,892,504 to SEK 19,067,504.

CFR announces the 2020 Best Company Project

Xspray Pharma Ab (publ) Share Price History (0GHZ) Follow 0GHZ. Buy. Sell.

Price.